Bayer Healthcare introduces six new medical products
Bayer Healthcare on Monday announced the launch of six new products that will be rolled out in Asia-Pacific over the next year and a half. The new products fall under the fields of ophthalmology, oncology and cardiology.
Among them is a product called EYLEA, which has been shown to improve sight to patients with wet Age-related Macular Degeneration (AMD), a disease that can lead to blindness.
With the new product, elderly patients who suffer from this disease can take their injection once every two months instead of once a month, according to Dr Chuan Kit Foo, Bayer Healthcare's Head of Medical Affairs in Asia-Pacific.
"It could potentially reduce the amount of hospital visits and allow patients to lead independent and better lives," said Dr Chuan referring to the new product.